Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Financial Results:
Jubilant Ingrevia Ltd reported Revenues for Q4FY24 of ₹1,074.00 Crores down from ₹1,145.00 Crore year on year, a fall of 6.2%.
Total Expenses for Q4FY24 of ₹1,033.00 Crores down from ₹1,079.00 Crores year on year, a fall of 4.26%.
Consolidated Net Profit of ₹29.00 Crores down 44.23% from ₹52.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.84, down 43.90% from ₹3.28 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.